Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.37 -0.03 (-6.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) EBIT Margin (2014 - 2026)

Updated

Citius Pharmaceuticals (CTXR) reported EBIT Margin of -785.39% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1145.56 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) EBIT Margin (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Citius Pharmaceuticals' EBIT Margin came in at -863.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Citius Pharmaceuticals 9.70 Mn -23.87 Mn 1.00 Mn -785.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -785.39%
Mar 31, 2026 -1,930.96%
Dec 31, 2025 -228.68%
Sep 30, 2016 -56,776,166.67%
Jun 30, 2016 -271,922.51%
Mar 31, 2016 -22,387,033.33%
Dec 31, 2015 -8,297,840.00%
Sep 30, 2015 -856,974.34%
Jun 30, 2015 -259,640.60%
Mar 31, 2015 -136,222.37%
Dec 31, 2014 -39,805.48%
API Access

Citius Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CTXR&period=max&api_key=YOUR_API_KEY